← Back to headlines
BridgeBio Pharma Achieves Record 2025 Revenue
BridgeBio Pharma reported record revenue for 2025, largely due to the commercial success of its drug Attruby.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
